Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Exenatide on Cortisol Secretion
NCT03160261Phase 4Completed
- Sponsor
- University of Tartu
- Start
- Sep 2017
- Primary completion
- Dec 2017
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of exenatide in type 2 diabetes mellitus (T2DM), sponsored by University of Tartu. Started Sep 2017; status: completed.
02
Drugs
exenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03160261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03160261.